In June 2025, Cell Reports Medicine published the results of an international clinical trial investigating Lisavanbulin, a new experimental pill for people with glioblastoma and other high-grade gliomas.
In June 2025, Cell Reports Medicine published the results of an international clinical trial investigating Lisavanbulin, a new experimental pill for people with glioblastoma and other high-grade gliomas.